homeHome Clinical Pathways Ophthalmology

Ophthalmology

Services

Service Specialists

The following treatments are not routinely funded by NHS North Somerset.

Policy Apply Access
Bevacizumab for treatment of choroidal neovascularisation associated with Angioid Streaks and Retinal Dystrophies
Issued: 15/4/2010
Approved: 8/07/10
Review: Earliest of either SHA guidance, NICE publication or one year from issue.		 Application Form CBA
Bevacizumab in the treatment of neovascular glaucoma due to ischaemic central retinal vein occlusion
Issued: 15/4/2010
Approved: 15/4/10
Review: Earliest of either SHA guidance, NICE publication or one year from issue.		 Application Form CBA
Bevacizumab in the treatment of non-ischaemic central retinal vein occlusion
Issued: 15/4/2010
Approved: 15/4/10
Review: Earliest of either SHA guidance, NICE publication or one year from issue.		 Application Form CBA
Blepharoplasty
Issued: June 2009
Approved: June 2009
Review: Earliest of either SHA guidance, NICE publication or five years from issue.		 Application Form PA
Cataract
Issued: November 2010 January 2010
Approved: November 2010
Review: Earliest of either SHA guidance, NICE publication or five years from issue.		 Application Form CBA
Chalazia
Issued: May 2011
Approved: April 2011
Review: Earliest of either SHA guidance, NICE publication or five years from issue.		 Application Form PA
Excimer Laser Eye Surgery
Issued: January 2010
Approved: January 2010
Review: Earliest of either SHA guidance, NICE publication or one year from issue.		 Application Form CBA
Glaucoma
Issued: July 2010
Approved:
Review:		 Application Form CBA
Intravitreal anti-VEGF Therapy in the Treatment of Diabetes-Related Eye Disease
Issued: April 2010
Approved:
Review: Earliest of either SHA guidance, NICE publication or one year from issue.		 Application Form PA
Multifocal Intraocular lenses
Issued: June 2011
Approved:
Review: Earliest of either SHA guidance, NICE publication or five years from issue.		 Application Form PA